Denmark’s economy was reshaped by Novo Nordisk and obesity drugs. That identity now is under attack on multiple fronts, from ...

The Harbor International Compounders ETF returned -9.22% compared to the MSCI All Country World ex-US Index, which returned ...

The Harbor International Compounders Fund returned -9.59% compared to the MSCI All Country World ex-US Index, which returned ...

XENICAL remains a well-recognized option for obesity management, offering clinically significant weight loss and metabolic benefits through a unique fat-blocking mechanism. However, its high ...

Today's Research Daily features new research reports on 16 major stocks, including The Procter & Gamble Company (PG), Novo ...

Equity markets may be struggling because of President Donald Trump's current economic policies, but that doesn't mean ...

Novo Nordisk NVO and Eli Lilly LLY dominate the diabetes and obesity market on the back of the tremendous success of their ...

Novo Nordisk , the producer of Ozempic, Wegovy and other medications, will invest 6.4 billion reais ($1.09 billion) in Brazil ...

Historical trends and future projections of the number of people with overweight and obesity suggest alarming parallel ...